• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠高血糖素(II)与胰高血糖素原的C末端序列(第33 - 69位氨基酸残基)相同的证据。

Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin.

作者信息

Holst J J

出版信息

Biochem J. 1982 Dec 1;207(3):381-8. doi: 10.1042/bj2070381.

DOI:10.1042/bj2070381
PMID:7165698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1153876/
Abstract

Enteroglucagon (II) was isolated from extracts of pig ileum mucosa by repeated gel filtrations, and its immunochemical and chromatographic characteristics were compared with those of a synthetic peptide corresponding to the 33-69 sequence of pig glicentin, before and after digestion with trypsin or trypsin followed by carboxypeptidase B, by using five region-specific assays covering most of the glicentin sequence. Enteroglucagon (II) and the synthetic peptide behave identically under three different conditions of chromatography as determined with all five assays (including a highly specific radioreceptor assay), and gave rise to similar fragments after enzyme digestion. It was therefore concluded that enteroglucagon (II) and the 33-69 sequence of glicentin are most probably identical.

摘要

通过反复凝胶过滤从猪回肠黏膜提取物中分离出肠高血糖素(II),并使用涵盖大部分胰高血糖素原序列的五种区域特异性检测方法,比较了其与猪胰高血糖素原33 - 69序列对应的合成肽在胰蛋白酶消化或胰蛋白酶后接羧肽酶B消化前后的免疫化学和色谱特征。在所有五种检测方法(包括高度特异性的放射受体检测)所确定的三种不同色谱条件下,肠高血糖素(II)和合成肽表现相同,并且酶消化后产生相似的片段。因此得出结论,肠高血糖素(II)和胰高血糖素原的33 - 69序列很可能是相同的。

相似文献

1
Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin.肠高血糖素(II)与胰高血糖素原的C末端序列(第33 - 69位氨基酸残基)相同的证据。
Biochem J. 1982 Dec 1;207(3):381-8. doi: 10.1042/bj2070381.
2
Evidence that glicentin contains the entire sequence of glucagon.胃泌酸调节素包含胰高血糖素完整序列的证据。
Biochem J. 1980 May 1;187(2):337-43. doi: 10.1042/bj1870337.
3
The biological significance of "enteroglucagon." Present status.“肠高血糖素”的生物学意义。现状。
Peptides. 1986;7 Suppl 1:37-42. doi: 10.1016/0196-9781(86)90161-0.
4
The primary structure of porcine glicentin (proglucagon).猪胰高血糖素原(胰高血糖素原)的一级结构。
Regul Pept. 1981 May;2(2):139-50. doi: 10.1016/0167-0115(81)90007-0.
5
Purification and sequence of rat oxyntomodulin.大鼠胃泌酸调节素的纯化与序列分析
Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9362-6. doi: 10.1073/pnas.91.20.9362.
6
Proglucagon processing in porcine and human pancreas.猪和人胰腺中胰高血糖素原的加工处理
J Biol Chem. 1994 Jul 22;269(29):18827-33.
7
Glucagon-related peptides in the human gastrointestinal mucosa.人类胃肠道黏膜中的胰高血糖素相关肽
Diabetologia. 1984 Mar;26(3):223-8. doi: 10.1007/BF00252412.
8
Glicentin 1-61 probably represents a major fraction of glucagon-related peptides in plasma of anaesthetized uraemic pigs.胰高血糖素原1-61可能是麻醉的尿毒症猪血浆中胰高血糖素相关肽的主要成分。
Diabetologia. 1986 Jul;29(7):462-7. doi: 10.1007/BF00506540.
9
Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.猪肠道和胰腺中胰高血糖素样免疫活性的分子形式。
Endocrinology. 1983 Mar;112(3):917-23. doi: 10.1210/endo-112-3-917.
10
The amino acid sequence of porcine glicentin.猪胰高血糖素样肽的氨基酸序列。
Peptides. 1981;2 Suppl 2:37-9. doi: 10.1016/0196-9781(81)90007-3.

引用本文的文献

1
Annual Prize Lecture 2024: Endogenous physiological mechanisms as basis for the treatment of obesity and type 2 diabetes.2024年年度获奖讲座:作为肥胖症和2型糖尿病治疗基础的内源性生理机制
J Physiol. 2024 Dec;602(24):6613-6629. doi: 10.1113/JP287461. Epub 2024 Nov 9.
2
Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases.重新审视胰高血糖素在健康、糖尿病及其他代谢性疾病中的作用。
Nat Rev Endocrinol. 2023 Jun;19(6):321-335. doi: 10.1038/s41574-023-00817-4. Epub 2023 Mar 17.
3
Discovery of the GI Effects of GLP-1: An Historical Perspective.GLP-1 的胃肠道作用的发现:历史视角。
Dig Dis Sci. 2022 Jul;67(7):2716-2720. doi: 10.1007/s10620-022-07519-3. Epub 2022 May 30.
4
Effect of the Natural Sweetener Xylitol on Gut Hormone Secretion and Gastric Emptying in Humans: A Pilot Dose-Ranging Study.天然甜味剂木糖醇对人体肠道激素分泌和胃排空的影响:一项初步的剂量范围研究。
Nutrients. 2021 Jan 8;13(1):174. doi: 10.3390/nu13010174.
5
Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study.2 型糖尿病患者接受减重手术后前、后胰高血糖素原肽分泌谱:1 年前瞻性研究。
BMJ Open Diabetes Res Care. 2020 Mar;8(1). doi: 10.1136/bmjdrc-2019-001076.
6
Glucagon-like peptide 1 (GLP-1).胰高血糖素样肽 1(GLP-1)。
Mol Metab. 2019 Dec;30:72-130. doi: 10.1016/j.molmet.2019.09.010. Epub 2019 Sep 30.
7
Methods and Guidelines for Measurement of Glucagon in Plasma.血浆胰高血糖素的测定方法和指南。
Int J Mol Sci. 2019 Oct 30;20(21):5416. doi: 10.3390/ijms20215416.
8
Paracrine crosstalk between intestinal L- and D-cells controls secretion of glucagon-like peptide-1 in mice.肠 L 细胞和 D 细胞之间的旁分泌串扰控制小鼠胰高血糖素样肽-1 的分泌。
Am J Physiol Endocrinol Metab. 2019 Dec 1;317(6):E1081-E1093. doi: 10.1152/ajpendo.00239.2019. Epub 2019 Sep 10.
9
Liraglutide improves the beta-cell function without increasing insulin secretion during a mixed meal in patients, who exhibit well-controlled type 2 diabetes and coronary artery disease.在患有控制良好的2型糖尿病和冠状动脉疾病的患者中,利拉鲁肽在混合餐期间可改善β细胞功能,而不增加胰岛素分泌。
Diabetol Metab Syndr. 2019 May 31;11:42. doi: 10.1186/s13098-019-0438-6. eCollection 2019.
10
From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy.从肠促胰岛素概念和GLP-1的发现到当今的糖尿病治疗
Front Endocrinol (Lausanne). 2019 Apr 26;10:260. doi: 10.3389/fendo.2019.00260. eCollection 2019.

本文引用的文献

1
Relationship of glicentin to proglucagon and glucagon in the porcine pancreas.猪胰腺中甘丙肽与胰高血糖素原及胰高血糖素的关系。
Nature. 1981 Feb 5;289(5797):514-6. doi: 10.1038/289514a0.
2
The primary structure of porcine glicentin (proglucagon).猪胰高血糖素原(胰高血糖素原)的一级结构。
Regul Pept. 1981 May;2(2):139-50. doi: 10.1016/0167-0115(81)90007-0.
3
Evidence that glicentin contains the entire sequence of glucagon.胃泌酸调节素包含胰高血糖素完整序列的证据。
Biochem J. 1980 May 1;187(2):337-43. doi: 10.1042/bj1870337.
4
Heterogeneity of somatostatin like immunoreactivity (SLI) in extracts of porcine, canine and human pancreas.猪、犬和人胰腺提取物中生长抑素样免疫反应性(SLI)的异质性。
Acta Endocrinol (Copenh). 1981 Dec;98(4):564-72. doi: 10.1530/acta.0.0980564.
5
Evidence for transformation of glucagon-like immunoreactivity of gut into pancreatic glucagon in vivo.体内肠道胰高血糖素样免疫反应性转化为胰腺胰高血糖素的证据。
Diabetes. 1981 Sep;30(9):792-4. doi: 10.2337/diab.30.9.792.
6
Purification of 125 I-glucagon by anion exchange chromatography.通过阴离子交换色谱法纯化125I-胰高血糖素。
Horm Metab Res. 1972 May;4(3):223-4. doi: 10.1055/s-0028-1097092.
7
Purification and characterization of a protein from porcine gut with glucagon-like immunoreactivity.具有胰高血糖素样免疫反应性的猪肠道蛋白的纯化与特性分析
Horm Metab Res. 1976 Sep;8(5):366-71. doi: 10.1055/s-0028-1093615.
8
Extraction, gel filtration pattern, and receptor binding of porcine gastrointestinal glucagon-like immunoreactivity.猪胃肠道胰高血糖素样免疫活性物质的提取、凝胶过滤图谱及受体结合情况
Diabetologia. 1977 Apr;13(2):159-69. doi: 10.1007/BF00745145.
9
Extrapancreatic glucagons.胰腺外胰高血糖素
Digestion. 1978;17(2):168-90. doi: 10.1159/000198107.
10
A radioreceptor-assay for glucagon: binding of enteroglucagon to liver plasma membranes.
Diabetologia. 1975 Jun;11(3):211-9. doi: 10.1007/BF00422324.